Mackenzie Financial Corp Reduces Position in Varex Imaging Co. (NASDAQ:VREX)

Mackenzie Financial Corp reduced its position in Varex Imaging Co. (NASDAQ:VREXFree Report) by 15.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,381 shares of the company’s stock after selling 1,854 shares during the quarter. Mackenzie Financial Corp’s holdings in Varex Imaging were worth $213,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in VREX. Louisiana State Employees Retirement System purchased a new stake in Varex Imaging in the fourth quarter worth $416,000. Allspring Global Investments Holdings LLC grew its holdings in shares of Varex Imaging by 0.5% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,033,263 shares of the company’s stock worth $62,182,000 after purchasing an additional 14,963 shares during the last quarter. Assenagon Asset Management S.A. increased its stake in Varex Imaging by 64.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 37,973 shares of the company’s stock worth $778,000 after buying an additional 14,949 shares during the period. Pacer Advisors Inc. bought a new stake in Varex Imaging during the 4th quarter valued at about $20,481,000. Finally, GSA Capital Partners LLP purchased a new stake in Varex Imaging in the 3rd quarter valued at about $1,831,000.

Varex Imaging Stock Performance

Shares of Varex Imaging stock opened at $16.91 on Tuesday. The company has a current ratio of 4.30, a quick ratio of 2.37 and a debt-to-equity ratio of 0.76. The stock’s fifty day moving average price is $17.39 and its 200-day moving average price is $18.56. The firm has a market cap of $686.55 million, a P/E ratio of 17.61, a P/E/G ratio of 2.42 and a beta of 0.69. Varex Imaging Co. has a 12 month low of $16.62 and a 12 month high of $23.90.

Varex Imaging (NASDAQ:VREXGet Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.05). Varex Imaging had a return on equity of 9.21% and a net margin of 5.08%. The business had revenue of $190.00 million for the quarter, compared to the consensus estimate of $187.97 million. During the same quarter in the previous year, the company earned $0.08 earnings per share. The firm’s revenue was down 7.6% on a year-over-year basis. On average, equities research analysts expect that Varex Imaging Co. will post 0.99 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, TheStreet lowered shares of Varex Imaging from a “b-” rating to a “c” rating in a research report on Tuesday, February 6th.

Check Out Our Latest Research Report on VREX

Varex Imaging Profile

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Stories

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREXFree Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.